Screening, Early Detection and Prevention of Hepato-Pancreato-Biliary (HPB) Cancers
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Causes, Screening and Diagnosis".
Deadline for manuscript submissions: 1 April 2025 | Viewed by 156
Special Issue Editor
2. University Hospital Southampton NHS Foundation Trust, Southampton SO16 6YD, UK
Interests: pancreatic cancer; new onset diabetes millitus; early detection; faster diagnosis; screening; prevention
Special Issue Information
Dear Colleagues,
Much of the morbidity and mortality caused by human cancer is related to late diagnosis, where surgical and pharmacologic therapies are less effective. Most late-stage pancreatic and liver cancers follow a palliative treatment pathway. Therefore, facilitating early diagnosis is an important strategy to achieve longer survival (WHO, guide to cancer early diagnosis, 2017).
In addition, there are measures which can prevent or reduce the chance of HPB cancer in at-risk populations. These measures have highlighted some pharmacological agents, vaccines and supplements that may be recommended for public use.
The growing understanding of genomic, epigenomic and machine learning pathways has led to a pronounced diversification of diagnostic options, and thus to a significant improvement in the early diagnosis of cancer.
In this Special Issue, innovative screening, early detection and prevention technologies will be highlighted from the perspective of basic, translational and clinical pathway research, with the overall goal of improving them and identifying new potential targets.
Dr. Zaed Z.R. Hamady
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- hepatobiliary cancer
- pancreatic cancer
- early detection
- diagnosis
- screening
- prevention
